Playback speed
10 seconds
Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAILORx and Prosigna Trials Affect Practice?
2,099 views
May 30, 2019
Login to view comments.
Click here to Login